Trials / Unknown
UnknownNCT03235921
Use of Nitroglycerine to Improve Signs of Poor Peripheral Perfusion in Patients With Traumatic Hemorrhagic Shock
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Hemorrhagic shock is a pathologic state in which intravascular volume and oxygen delivery are impaired. During circulatory failure associated with hypovolemia and low cardiac output, redistribution of blood flow caused by increased vasoconstriction results in decreased perfusion of the skin. Skin temperature and capillary refill time has been advocated as a measure of peripheral perfusion.
Detailed description
Perfusion index (PI) is a non-invasive numerical value of peripheral perfusion obtained from pulse oximetry, it is an indicator of the pulse strength at the sensor site. The PI's values range from 0.2% for very weak pulse to 20% for extremely strong pulse according to patient's physiological conditions and monitoring sites. Large increases in lactate (i.e. \> 5 mmol/L) usually only occur due to hypoperfusion or muscle activity such as exercise or seizures. This study will investigate the role of nitroglycerine patch in improving the peripheral perfusion in poly traumatized patient with hemorrhagic shock for the first time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nitroglycerin patch 5mg | application of the nitroglycerin patch 5 mg to each patient in nitroglycerin group |
| OTHER | placebo | no drug given to the control group |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2017-08-01
- Completion
- 2017-10-01
- First posted
- 2017-08-01
- Last updated
- 2017-08-01
Locations
2 sites across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03235921. Inclusion in this directory is not an endorsement.